First Horizon Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-111
| Closed | -$4.51K | – | 2486 |
|
|
2023
Q2 | $4.51K | Hold |
111
| – | – | ﹤0.01% | 1824 |
|
|
2023
Q1 | $5.38K | Buy |
111
+27
| +32% | +$1.31K | ﹤0.01% | 1791 |
|
|
2022
Q4 | $3.21K | Sell |
84
-89
| -51% | -$3.4K | ﹤0.01% | 1924 |
|
|
2022
Q3 | $9K | Buy |
173
+1
| +0.6% | +$52 | ﹤0.01% | 1561 |
|
|
2022
Q2 | $7K | Sell |
172
-75
| -30% | -$3.05K | ﹤0.01% | 1722 |
|
|
2022
Q1 | $9K | Buy |
247
+2
| +0.8% | +$73 | ﹤0.01% | 1141 |
|
|
2021
Q4 | $10K | Hold |
245
| – | – | ﹤0.01% | 1522 |
|
|
2021
Q3 | $9K | Hold |
245
| – | – | ﹤0.01% | 1574 |
|
|
2021
Q2 | $10K | Buy |
245
+2
| +0.8% | +$82 | ﹤0.01% | 1352 |
|
|
2021
Q1 | $12K | Buy |
243
+28
| +13% | +$1.38K | ﹤0.01% | 1243 |
|
|
2020
Q4 | $13K | Buy |
215
+31
| +17% | +$1.87K | ﹤0.01% | 1013 |
|
|
2020
Q3 | $9K | Hold |
184
| – | – | ﹤0.01% | 1040 |
|
|
2020
Q2 | $9K | Buy |
184
+15
| +9% | +$734 | ﹤0.01% | 1049 |
|
|
2020
Q1 | $8K | Buy |
+169
| New | +$8K | ﹤0.01% | 1002 |
|